Roche set to challenge NICE Tarceva decision
November 25, 2010Sales and Marketing NICE, Roche, Roche UK, Tarceva, erlotinib, lung cancer
NICE has again rejected Roche’s lung cancer drug Tarceva in its second round of draft guidance. Tarceva (erlotinib) was being …
The renal cell carcinoma market: Votrient to challenge Sutent’s lead
November 25, 2010Sales and Marketing GSK, GlaxoSmithKline, Pfizer, Sutent, Votrient, rcc, renal cell carcinoma
After decades of no new medicines emerging to treat renal cell carcinoma, no fewer than five new drugs were approved …
GSK sells antibiotics assets to Dr Reddy’s
November 24, 2010Manufacturing and Production, Sales and Marketing Antibiotics, Dr Reddy's, GSK
Dr. Reddy’s Laboratories has bought a US oral penicillin facility from GSK, along with the US marketing rights to the …
Varnish chemical migrates into medicine bottles, says study
November 24, 2010Manufacturing and Production AAPS, HDPE, chemical migration, varnish
A chemical found in the varnish coating of pharmaceutical bottles has been show to migrate into the contents and be …
Brain cancer vaccine to move into phase III
November 24, 2010Research and Development, Sales and Marketing Celldex, Pfizer, brain cancer, glioblastoma
Celldex will press ahead with large-scale trials of its vaccine treatment for brain cancer after encouraging phase II results. The …
NICE recommends Herceptin for gastric cancer, blocks high dose Glivec
November 24, 2010Sales and Marketing Cancer, GIST, Glivec, HER2, Herceptin, NICE, gastric cancer
NICE has recommended Roche’s cancer drug Herceptin for patients with HER2 metastatic gastric cancer. NICE was initially minded not to …
Healthcare, politics and the NHS
November 24, 2010Research and Development Academy of Medical Sciences, Les Roes, NHS, clinical trials, clinical trials governance, evidence-based medicine
I have just participated in a consultation by the Academy of Medical Sciences on the regulation and governance of clinical …
Pharma manufacturing news in brief
November 23, 2010Manufacturing and Production Alpah Biologics, Alpha Biologics, Kemwell, Lonza, Phil Taylor, Roche
Facility updates from Roche, Alpha Biologics, Kemwell and Reinnervate, new contract services from Lonza and Patheon, plus a milestone in …
Brinsmead to be life sciences adviser to government
November 23, 2010Sales and Marketing Brinsmead, NHS, government, life sciences
Chris Brinsmead, chairman of AstraZeneca UK, has been made the government’s life sciences business adviser. He was appointed by universities …
Roche to develop diagnostic tools for Tarceva
November 23, 2010Sales and Marketing Genzyme, NSCLC, Roche, Tarceva, diagnostic
Roche has obtained a worldwide sub-license from Genzyme to develop a diagnostic kit for the detection of specific mutations for …
Vytorin cuts heart problems in kidney patients
November 23, 2010Sales and Marketing Merck, Vytorin, cardiovascular, simvastatin
Vytorin has been shown to reduce potentially heart problems in patients with chronic kidney disease (CKD) in a new study. …
Offshore outsourcing in Regulatory Affairs and Pharmacovigilance
November 22, 2010Sales and Marketing Kinapse, White paper
Based on Kinapse’s direct experience, we explore the emerging environment for regulatory and pharmacovigilance offshore outsourcing within the biopharmaceutical industry …
A new generation of analogues for valuing strategy
November 22, 2010Sales and Marketing Alex Blyth, MSI, forecasting, marketing, marketing strategy
Anyone who is involved in the planning of pharma marketing campaigns will know that the Holy Grail is trying to …
Chris King joins Synovate Healthcare
November 22, 2010Sales and Marketing Chris King, Synovate Healthcare, appointment, sales and marketing
Synovate has appointed Chris King head of its European Oncology Monitor within its specialist healthcare research division. He joins the …
Bayer’s challenger to Lucentis shows promise
November 22, 2010Research and Development, Sales and Marketing Bayer, Lucentis, Novartis, Regeneron, Roche, VEGF Trap-Eye, age-related macular degeneration, avastin, wet AMD
Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …
J&J and Takeda issue recall for cancer drug Velcade
November 22, 2010Manufacturing and Production J&J, JJ, Johnson & Johnson, Takeda Pharmaceuticals, Velcade, bortezomib, pharma manufacturing, product recalls
Johnson & Johnson has been affected by another product recall, on this occasion concerning the cancer drug Velcade (bortezomib) sold …
Daiichi-Sankyo cleared of rep misconduct
November 22, 2010Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Daiichi Sankyo, Daiichi-Sankyo, Olmetec, PMCPA, olmesartan, pharma sales representative
Daiichi-Sankyo has been cleared of any wrongdoing in relation to the ABPI Code after one of its representatives was accused …
Pfizer’s axitinib impresses in head-to-head trial with Nexavar
November 22, 2010Research and Development, Sales and Marketing Kidney cancer, Nexavar, Pfizer, axitinib, mRCC, metastatic renal cell carcinoma
Pfizer’s axitinib has impressed in phase III trials assessing its efficacy as a second line treatment for renal cell carcinoma. …
Digital Pharma: E-Health and the European agenda
November 19, 2010Medical Communications Digital Agenda, Digital Pharma blog, EC, European Commission, Neelie Kroes, digital patients, e-health, electronic patient records
The European Commission wants all European patients to be given secure online access to their medical records by 2015 and …
Pharma sector growth to improve in 2011
November 19, 2010Sales and Marketing 2011, IMS, IMS Health, forecast, growth, pharma
2011 should be a better year for pharma as emerging markets and recovering economies will help growth, say analysts at …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
